全文获取类型
收费全文 | 5808篇 |
免费 | 448篇 |
国内免费 | 34篇 |
专业分类
耳鼻咽喉 | 58篇 |
儿科学 | 256篇 |
妇产科学 | 80篇 |
基础医学 | 780篇 |
口腔科学 | 149篇 |
临床医学 | 520篇 |
内科学 | 1252篇 |
皮肤病学 | 43篇 |
神经病学 | 528篇 |
特种医学 | 583篇 |
外科学 | 756篇 |
综合类 | 91篇 |
预防医学 | 485篇 |
眼科学 | 112篇 |
药学 | 328篇 |
中国医学 | 3篇 |
肿瘤学 | 266篇 |
出版年
2023年 | 16篇 |
2022年 | 36篇 |
2021年 | 74篇 |
2020年 | 60篇 |
2019年 | 83篇 |
2018年 | 100篇 |
2017年 | 65篇 |
2016年 | 78篇 |
2015年 | 104篇 |
2014年 | 147篇 |
2013年 | 231篇 |
2012年 | 289篇 |
2011年 | 355篇 |
2010年 | 255篇 |
2009年 | 203篇 |
2008年 | 299篇 |
2007年 | 284篇 |
2006年 | 357篇 |
2005年 | 291篇 |
2004年 | 288篇 |
2003年 | 244篇 |
2002年 | 287篇 |
2001年 | 92篇 |
2000年 | 83篇 |
1999年 | 92篇 |
1998年 | 204篇 |
1997年 | 162篇 |
1996年 | 150篇 |
1995年 | 125篇 |
1994年 | 101篇 |
1993年 | 118篇 |
1992年 | 65篇 |
1991年 | 75篇 |
1990年 | 62篇 |
1989年 | 94篇 |
1988年 | 65篇 |
1987年 | 69篇 |
1986年 | 69篇 |
1985年 | 63篇 |
1984年 | 49篇 |
1983年 | 55篇 |
1982年 | 44篇 |
1981年 | 34篇 |
1980年 | 48篇 |
1979年 | 33篇 |
1978年 | 28篇 |
1977年 | 23篇 |
1976年 | 31篇 |
1975年 | 32篇 |
1972年 | 16篇 |
排序方式: 共有6290条查询结果,搜索用时 0 毫秒
1.
2.
Inhibition by oral N-acetylcysteine of cigarette smoke-induced "bronchitis" in the rat 总被引:1,自引:0,他引:1
Specific pathogen-free rats were exposed to the cigarette smoke (CS) of 25 cigarettes daily for 14 days and concurrently given N-acetylcysteine (Nac) as 1% of their drinking water (average daily dose 973 mg/kg). The thickness of the epithelium was measured at four airway levels and the numbers of mucus-containing secretory cells, stained for neutral or acidic glycoprotein (NGP or AGP respectively), were counted in surface epithelium at eight airway levels. Cigarette smoke increased the thickness of the epithelium at three of the airway levels studied by between 37 and 72%. The number of secretory cells was increased at all airway levels distal to the upper trachea by between 102 and 421%. Secretory cells containing NGP were reduced in number but this was more than offset by a large increase in the number of secretory cells containing AGP at all airway levels. N-acetylcysteine inhibited CS-induced epithelial thickening. Nac also inhibited the CS-induced increase in the number of secretory cells with AGP, but had little effect on the CS-induced reduction in the number of cells with NGP. Thus, prophylactic oral N-acetylcysteine led to an overall inhibition of CS-induced mucous cell hyperplasia and epithelial hypertrophy. The results suggest a novel anti-inflammatory action for a drug with known mucolytic effects. 相似文献
3.
4.
Hong Wang Venkatraman Siddharthan Jeffery O. Hall John D. Morrey 《Journal of neurovirology》2009,15(4):293-299
Prior findings led us to hypothesize that West Nile virus (WNV) preferentially transports along motor axons instead of sensory
axons. WNV is known to undergo axonal transport in cell culture and in infected hamsters to infect motor neurons in the spinal
cord. To investigate this hypothesis, WNV was injected directly into the left sciatic nerve of hamsters. WNV envelope-staining
in these hamsters was only observed in motor neurons of the ipsilateral ventral horn of the spinal cord, but not in the dorsal
root ganglion (DRG). To evaluate the consequence of motor neuron infection by WNV, the authors inoculated wheat germ agglutinin—horseradish
peroxidase (WGA-HRP) 9 days after WNV sciatic nerve injection, and stained the spinal cord and the DRG for HRP activity 3
days later. The degree of HRP-staining in DRG was the same in WNV- and sham-infected animals, but the HRP-staining in the
motor neuron in the ventral horn was considerably less for WNV-infected hamsters. To investigate the mechanism of WNV transport,
hamsters were treated with colchicine, an inhibitor of membranous microtubule-mediated transport. The intensity of the WNV-stained
area in the spinal cord of colchicine-treated hamsters at 6 days after WNV infection were significantly reduced (P≤.05) compared to the placebo-treated hamsters. These data suggest that WNV is preferentially transported through the motor
axons, but not the sensory axons, to subsequently infect motor neurons and cause motor weakness and paralysis. 相似文献
5.
Jeffery H Wootton Anthony B Ross Chris J Diederich 《International journal of hyperthermia》2007,23(8):609-622
PURPOSE: This study was designed to assess pelvic bone temperature during typical treatment regimens of transurethral ultrasound thermal ablation of the prostate to establish guidelines for limiting bone heating. METHODS: Treatment with transurethral planar, curvilinear, and sectored tubular applicators was simulated using an acoustic and biothermal pelvic model that accommodates applicator sweeping, boundary temperature control, and changes in perfusion and attenuation with thermal dose to more accurately model ultrasound energy penetration. The effects of various parameters including power and frequency (5-10 MHz) on bone heating were assessed for a range of prostate cross-sections (3-5 cm) and bone distances (1-3 cm). RESULTS: All devices can produce significant bone heating (temperatures >50 degrees C, thermal dose >240 EM(43 degrees C)) without optimization of applied frequency or power for bone <3 cm from the prostate boundary. In small glands ( approximately 3 cm) increasing operating frequency of curvilinear and planar devices can increase bone temperatures, whereas the tubular applicator can be used at 10 MHz to avoid likely bone damage. In larger prostates (4-5 cm wide) increasing frequency reduces bone heating but can substantially increase treatment time. Lowering power can reduce bone temperature but may increase thermal dose by increasing treatment duration. All applicators can be used to treat glands 4-5 cm with limited bone heating by selecting appropriate power and frequency. CONCLUSIONS: Pubic bone heating during ultrasound thermal therapy of the prostate can be substantial in certain situations. Successful realization of this therapy will require patient-specific treatment planning to optimally determine power and frequency in order to minimize bone heating. 相似文献
6.
7.
Jeffery R Gray 《Clinical laboratory science》2006,19(4):214-217
This paper explains the background and current use of B-type natriuretic peptide (BNP) assays to differentiate congestive heart failure (CHF) from other causes of dyspnea. With a large and growing elderly population, CHF is being diagnosed much more often in emergency rooms in the United States. Doctors need a way to quickly distinguish whether a patient with respiratory distress is suffering from cardiac insufficiency or another etiology. BNP is released from the ventricles in response cardiac overload from CHF or some other form of left ventricular systolic dysfunction. Therefore, the detection and measurement of BNP is a fast and accurate method of determining if CHF is the cause of a patient's breathing difficulties. 相似文献
8.
9.
Phaeohyphomycotic cutaneous disease caused by Pleurophoma in a cardiac transplant patient 总被引:2,自引:0,他引:2
D P Dooley M L Beckius B S Jeffery C K McAllister W H Radentz A R Feldman M G Rinaldi S R Bailey J H Keeling 《The Journal of infectious diseases》1989,159(3):503-507
A 56-y-old female cardiac transplant patient treated with cyclosporine and prednisone noted the onset of three nontender red nodules on the legs and arms after gardening. Biopsy of all lesions revealed inflammatory cells and hyphal elements in the dermis. The dematiaceous fungus cultured from biopsy tissue was a pycnidial-forming organism of the genus Pleurophoma. The lesions responded to the topical application of miconazole. 相似文献
10.
Indomethacin and flurbiprofen speed recovery of rat bronchial epithelium after exposure to cigarette smoke 总被引:1,自引:0,他引:1
The cigarette smoke-induced rat model of chronic bronchitis was used to study the time course of the return of cigarette smoke-induced secretory cell hyperplasia to the normal and the capacity of two non-steroidal anti-inflammatory drugs to speed this recovery. Cigarette smoke alone significantly increased (P less than 0.05) the number of secretory cells in all of the eight airway levels studied to between 52-225% above control values. After cessation of exposure, recovery was complete by 9 days in the trachea, between 10-21 days in 'proximal' intrapulmonary airways and 43-84 days in distal bronchioli. Indomethacin and flurbiprofen, given by intraperitoneal injection at 4 mg/kg body weight for 21 days of the recovery period, significantly reduced the time taken for recovery to between 4 and 9 days in intrapulmonary airways but had no effect in the trachea. 相似文献